Amiee Luan Kang
About Amiee Luan Kang
Amiee Luan Kang is the Director of Worldwide Health Economics and Outcomes Research (HEOR) at Bristol Myers Squibb, with extensive experience in HEOR across multiple pharmaceutical companies.
Title
Amiee Luan Kang currently holds the position of Director, WW HEOR at Bristol Myers Squibb. Her extensive experience and detailed understanding of health economics and outcomes research (HEOR) have significantly contributed to her current leadership role at the company.
Current Role at Bristol Myers Squibb
Since 2021, Amiee Luan Kang has been appointed as the Director, WW HEOR at Bristol Myers Squibb. In this role, she oversees various critical projects related to health economics and outcomes research, ensuring effective assessment and optimization of health outcomes for new and existing treatments.
Professional Experience
Amiee Luan Kang's career spans multiple prestigious roles within the pharmaceutical industry. She served as Associate Director Worldwide HEOR at Bristol Myers Squibb from 2018 to 2021. Prior to that, she was Sr. Manager of health outcomes and value assessment at Pacira Pharmaceuticals, Inc. from 2015 to 2018, and Trauma Research Director in the Surgical Department at Nassau University Medical Center from 2014 to 2015.
Early Career and Internships
Amiee Luan Kang's early career includes significant roles that built her expertise in HEOR. She was a Project Manager for Global Health Outcomes at Merck from 2013 to 2014 and completed a fellowship in Health Economics and Outcome Research at Daiichi Sankyo from 2011 to 2013. Additionally, she gained early research experience as an Epidemiology Research Assistant at UMDNJ from 2009 to 2011. She also worked as a Summer Research Intern at New Jersey Hospital Association in 2011.
Education and Academic Background
Amiee Luan Kang holds a Master of Public Health (MPH) in Epidemiology from the University of Medicine and Dentistry of New Jersey, obtained from 2009 to 2011. She also earned a Bachelor of Science (BS) in Biological and Biomedical Sciences from Rutgers, The State University of New Jersey-New Brunswick, studying from 2004 to 2008.